Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs

✍ Scribed by Quiralte, Joaquín; Delgado, Julio; de San Pedro, Blanca Sáenz; López-Pascual, Esperanza; Nieto, Maria A.; Ortega, Nancy; Florido, Jose Fernando; Conde, José

• Book ID: 122671261
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 137 KB
• Volume: 93
• Category: Article
• ISSN: 1081-1206
• DOI: 10.1016/S1081-1206(10)61395-6